Pages that link to "Q28115464"
Jump to navigation
Jump to search
The following pages link to MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality (Q28115464):
Displaying 50 items.
- Bcl2 modifying factor (Q21100295) (← links)
- MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations (Q26773183) (← links)
- Oncogenic MicroRNAs: Key Players in Malignant Transformation (Q26773316) (← links)
- Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis (Q26783620) (← links)
- Role of MicroRNAs-221/222 in Digestive Systems (Q26799877) (← links)
- The role of microRNAs in human liver cancers (Q26861699) (← links)
- MicroRNA in cancer: new hopes for antineoplastic chemotherapy (Q27001048) (← links)
- The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update (Q27003050) (← links)
- The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity (Q27010233) (← links)
- Role of microRNAs in hepatocellular carcinoma: a clinical perspective (Q27014034) (← links)
- Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma (Q27026846) (← links)
- Emerging role of microRNAs in liver diseases (Q27490492) (← links)
- TP53/MicroRNA Interplay in Hepatocellular Carcinoma (Q28073980) (← links)
- Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention (Q28080281) (← links)
- Guide for diagnosis and treatment of hepatocellular carcinoma (Q28084003) (← links)
- MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3 (Q28118646) (← links)
- Molecular classification and novel targets in hepatocellular carcinoma: recent advancements (Q28383646) (← links)
- From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms (Q28383729) (← links)
- Retracted: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells (Q31116416) (← links)
- Molecular genetics of hepatocellular neoplasia. (Q33680701) (← links)
- MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27 (Q33756226) (← links)
- miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways (Q33787523) (← links)
- MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer (Q33829462) (← links)
- MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. (Q33942272) (← links)
- miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression (Q33980238) (← links)
- Micromarkers: miRNAs in cancer diagnosis and prognosis. (Q34108602) (← links)
- Therapeutics Based on microRNA: A New Approach for Liver Cancer (Q34152847) (← links)
- ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer (Q34168267) (← links)
- The clinical potential of microRNAs (Q34220723) (← links)
- MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma (Q34256676) (← links)
- Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival (Q34282931) (← links)
- miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer (Q34490836) (← links)
- The role of microRNAs in liver cancer progression. (Q34543731) (← links)
- Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro (Q34548464) (← links)
- Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence (Q34630306) (← links)
- A meta-analysis of microRNA expression in liver cancer. (Q34662934) (← links)
- MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. (Q34675280) (← links)
- Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis (Q34796325) (← links)
- Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. (Q34923649) (← links)
- miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1 (Q34923751) (← links)
- Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance (Q35017844) (← links)
- Emerging role of microRNA in hepatocellular carcinoma (Review) (Q35042179) (← links)
- The "Macro" World of microRNAs in Hepatocellular Carcinoma. (Q35215896) (← links)
- Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. (Q35343911) (← links)
- MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine (Q35715931) (← links)
- Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad. (Q35737785) (← links)
- Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221. (Q35781516) (← links)
- MicroRNAs and Gastroenterological Cancers (Q35949461) (← links)
- IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment (Q36030286) (← links)
- New strategies in hepatocellular carcinoma: genomic prognostic markers. (Q36090222) (← links)